Earlier this year, Department of Genetics professor Joel Sax, along with Christopher McFarland, assistant professor at the Department of Genetics and Genome Sciences, and Bryan Carroll, associate professor for the Department of Dermatology, published an article titled 'Limitations of the Commercially Available Gene Expression Test in Predicting...
Researchers highlight the limitations of a specific commercially available clinical genetic test in dermatology retrieved 26 July 2024 from https://medicalxpress.com/news/2024-07-highlight-limitations-specific-commercially-clinical.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Feb 26, 2018Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Boost in infant genetics research could change lives, say researchersInvestment in research into genetics could dramatically improve educational policies and understanding of parenting in ways that could help all children, according to a new paper led by the University of Surrey.
Read more »
New patterns in cancer genetics point at tumor suppressor genes as potential therapeutic targetsCancer is caused by genetic changes that occur in our cells over time. There are two main types of changes, namely somatic mutations, which are alterations in the DNA sequence, and copy number alterations, which are changes in the number of copies of a particular gene.
Read more »
Study addresses a long-standing diversity bias in human geneticsMost research in human genetics has historically focused on people of European ancestries—a long-standing bias that may limit the accuracy of scientific predictions for people from other populations.
Read more »
Boy whose cancer was half the size of a lung takes part in genetics trialEddie Pessoa de Araujo was diagnosed with T-cell acute lymphoblastic leukaemia and underwent treatment at Great Ormond Street.
Read more »
Penn researchers aim to uncover the underlying biological mechanisms of TBI-related neurodegenerationA team of researchers led by Penn Medicine will investigate the link between traumatic brain injuries (TBI) and Alzheimer's disease and related dementias (ADRD) over the next five years with a $10 million grant from the National Institute of Neurological Disorders and Stroke (NINDS).
Read more »
Researchers develop scalable synthesis of cancer-fighting compoundsWithanolides, a class of naturally occurring compounds found in plants, have long been a focus of cancer research due to their ability to inhibit cancer cell growth, induce cell death and prevent metastasis. These compounds are important in developing new cancer treatments.
Read more »